(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)
Nov 10 (Reuters) - European shares hovered at eight-month highs on Tuesday on optimism around signs of a breakthrough in developing a COVID-19 vaccine, although concerns about the depth of the economic damage from the pandemic capped gains.
The pan-European STOXX 600 was up 0.2% by 0804 GMT, after rallying 4% in the previous session, as U.S. drugmaker Pfizer Inc said its COVID-19 vaccine, developed with German partner BioNTech SE, was more than 90% effective in preventing the infection.
Banking, travel and leisure, and energy stocks were among the biggest gainers in early trading following gains of more than 7% on Monday.
In company news, German sportswear firm Adidas fell 2.2% even as it said it expects sales to return to growth in China in the fourth quarter. (Reporting by Sagarika Jaisinghani in Bengaluru; editing by Uttaresh.V)
Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.
Sign up for a free trial of our full service at https://www.breakingviews.com/trial and follow us on Twitter @Breakingviews and at www.breakingviews.com. All opinions expressed are those of the authors.